ERCC2 p.Arg683Gln
c.2048G>A · rs758439420 · VCV264679
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9978 | likely pathogenic ✓ concordant with ClinVar · top 8% in ERCC2 |
|---|---|---|
| REVEL | 0.934 | strongly pathogenic-leaning |
| SaProt | LLR -13.71 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | Δ0.98 | acceptor gain · deltas |
| Pangolin | Δ0.60 | gain · loss 0.03 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 17 kb · p 0.48 · regional, not allelic |
| Overall | ||
| CADD | 37.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0164% | 6,080 |
| South Asian | 0.00768% | 13,013 |
| East Asian | 0.00446% | 22,446 |
| African / African-American | 0.004% | 24,974 |
| Admixed American | 0.00167% | 59,992 |
| European (non-Finnish) | 0.000678% | 147,492 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ERCC2
- Protein
- p.Arg683Gln
- Coding
- c.2048G>A
- MANE Select
- NM_000400
- dbSNP
- rs758439420
- Type
- single nucleotide variant
- Location
- chr19:45352351 (GRCh38)
- Gene constraint
- LOEUF 1.089 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 87.74 · 55 PDB
- Residue 683
- an α-helix; a UniProt-annotated variant site (in xp-d); a UniProt-annotated variant site (in xp-d; vitamin d-mediated activation of cyp24a1 is impaired in patient fibroblasts due to altered tfiih-dependent phosphorylation of ets1, subsequent impaired cooperation of ets1 with vdr and altered vdr recruitment to cyp24a1 promoter; damaged dna opening by tfiih is impeded)
Similar variants
- ERCC2 p.Arg683Trp Pathogenic/Likely pathogenic ★★ same residue
- ERCC2 p.Arg683= Likely benign ★★ same residue
- ERCC2 c.1238-1G>C Likely pathogenic ★★ same condition
- ERCC2 c.1308-2A>G Likely pathogenic ★★ same condition
- ERCC2 c.1378-1G>T Pathogenic/Likely pathogenic ★★ same condition
- ERCC2 c.1479+2T>C Pathogenic/Likely pathogenic ★★ same condition
- ERCC2 c.1480-1G>C Pathogenic/Likely pathogenic ★★ same condition
- ERCC2 c.1480-2A>C Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ercc2-p-arg683gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown